ARCHIVES

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007

NCI-Approved CTEP Trials For The Month of July

July 27, 2012

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

NCI RFA: Basic Biobehavioral Research

August 6, 1999